Clinical Trial Update: Off Label Use of Infliximab in Adult Patients With Severe Eosinophilic Esophagitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update reports on the off-label use of infliximab for adults with severe eosinophilic esophagitis; the study is listed as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Remicade (infliximab)

Snippet

Sponsor: Swiss EE Study Group | Conditions: Esophagitis | Phase 2 | Status: COMPLETED